Published October 2000 | Version v1
Report Restricted

Non-invasive imaging of human telomerase activity-targeting enzyme in BNCT

  • 1. Kyoto Prefectural Univ. of Medicine, Dept. of Neurosurgery, Kyoto (Japan)
  • 2. Kyoto Univ., Kumatori, Osaka (Japan). Research Reactor Inst
  • 3. Nishijin Hospital, Kyoto (Japan)
  • 4. Maizuru National Hospital, Kyoto (Japan)

Description

In the present study, we achieved non-invasive imaging of gene expression of human telomerase (hTRT) in brain tumors by systemic administration of antisense peptide nucleic acid (PNA) and phosphorothioate-derivative (S-oligomer) labeled with 11C as a positron emitter. The difference in the rate of incorporation of antisense between the tumor and the surrounding normal brain tissue is large enough to apply this technique practically to non-invasive imaging of gene expression in humans using positron emission tomography (PET). We also expected that this technique can be used in developing the peculiar boron carrier in the neutron capture therapy. (author)

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Part of:
Proceedings of the ninth international symposium on neutron capture therapy for cancer

Additional details

Publishing Information

Imprint Title
Proceedings of the ninth international symposium on neutron capture therapy for cancer
Imprint Pagination
369 p.
Journal Page Range
p. 327-328
Report number
KURRI-KR--54

Conference

Title
9. international symposium on neutron capture therapy for cancer
Dates
2-6 Oct 2000
Place
Osaka (Japan)

Optional Information

Notes
4 refs., 1 fig.